This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Zentiva, A.s.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Ludmila Hejtmánková: Innovator in Antidiabetic Agents
Introduction
Ludmila Hejtmánková is a notable inventor based in Prelouc, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic agents. Her innovative work has led to the creation of a method for obtaining pioglitazone, a compound used in the treatment of diabetes.
Latest Patents
Ludmila holds a patent for a method titled "Method for obtaining pioglitazone as an antidiabetic agent." This method involves a series of chemical processes, including the condensation of a 4-derivatized phenol or phenolate, diazotization of amino groups, and cyclization with thiourea, ultimately leading to the synthesis of pioglitazone.
Career Highlights
Ludmila Hejtmánková is associated with Zentiva, a.s., where she has been instrumental in advancing pharmaceutical research. Her work has not only contributed to the scientific community but has also had a positive impact on the treatment of diabetes.
Collaborations
She has collaborated with notable colleagues, including Ales Halama and Petr Lustig, to further enhance her research and development efforts in the pharmaceutical industry.
Conclusion
Ludmila Hejtmánková's innovative approach to developing antidiabetic agents exemplifies her dedication to improving healthcare solutions. Her contributions continue to influence the field of pharmaceuticals positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile